California Technology Ventures

California Technology Ventures, LLC (CTV) is a venture capital investment firm based in Pasadena, California, founded in 1999. The firm specializes in making direct investments in technology and life science companies, focusing on information and communications technology, including computer hardware, telecommunications, and software, as well as life sciences sectors like bio-pharmaceuticals and medical devices. CTV is known for its entrepreneurial investment approach and is capable of supporting both early-stage and later-stage companies. Initial investments typically range from $250,000 to $2 million, with the potential to exceed $5 million over the investment period. The firm actively seeks opportunities in companies with experienced management, unique products or services that address significant needs, and a strong potential for leadership in growing industries. CTV emphasizes a compelling business model with clear milestones for profitability and a sustainable competitive advantage.

Andrea DeVita

Director of Finance

William Hanna

Co-Founder and Managing Director

42 past transactions

Motive

Series F in 2022
Motive is a technology company building technology to improve the safety, productivity, sustainability, and profitability of businesses that power the physical economy. Combined with AI, the Motive platform gives you complete visibility and control and significantly reduces manual workloads by automating and simplifying tasks. Motive serves small businesses across a wide range of industries, including transportation and logistics, construction, energy, field service, manufacturing, agriculture, food and beverage, retail, and the public sector. Motive is a fully unified integrated operations platform, combining driver safety, fleet management, equipment monitoring, and spend management all in one place.

Rally

Venture Round in 2021
Rally is a decentralized blockchain platform that enables creators to develop video streaming and gaming applications while fostering vibrant, self-sustaining economies within their communities. The platform empowers individuals with online communities to create their own digital coins without requiring coding expertise on the Ethereum blockchain. By offering digital assets and facilitating deeper engagement between creators and their fans, Rally supports additive monetization strategies for digital celebrities, allowing them to generate income through innovative value exchange. As a user-controlled network, Rally ensures that creators and their communities can utilize their social tokens across various social platforms.

AiVita Biomedical

Series B in 2020
AiVita Biomedical is a biotechnology company focused on advancing commercial and clinical-stage programs that utilize curative and regenerative medicines. Founded in 2016 and based in Irvine, California, the company develops treatments for cancer, including a patient-specific immunotherapy targeting advanced cancers such as glioblastoma and ovarian cancer. Additionally, AiVita Biomedical is engaged in a preclinical program that involves human stem cells differentiated into retinal tissue sheets aimed at treating degenerative retinal diseases. The company's offerings also include a line of rejuvenating skincare products under the ROOT OF SKIN brand, which focuses on anti-aging solutions. Through its expertise in stem cell growth and differentiation, AiVita Biomedical aims to create safe and effective manufacturing systems that support its diverse therapeutic pipeline.

MakerDAO

Private Equity Round in 2019
MakerDAO is a decentralized autonomous organization that operates on the Ethereum blockchain, specializing in the development of a stablecoin known as Dai. Founded in 2014 and headquartered in Santa Cruz, California, with additional offices in Copenhagen, Denmark, MakerDAO aims to minimize the price volatility of Dai by utilizing collateralized debt positions and autonomous feedback mechanisms. The company enables users to access a low-volatility, collateral-backed cryptocurrency, promoting financial inclusion and stability. In addition to Dai, MakerDAO has introduced MKR, a token that serves multiple purposes within its ecosystem, including governance and system recapitalization. Through its innovative approach, MakerDAO seeks to provide a decentralized digital currency that maintains its purchasing power, making financial services accessible to users worldwide.

MariaDB

Series C in 2017
MariaDB is a cloud database company that specializes in providing next-generation database solutions. Its products have been widely adopted, reaching over a billion users through various Linux distributions and accumulating more than one billion downloads. MariaDB serves a diverse range of industries and use cases, operating primarily within the Software-as-a-Service (SaaS) sector. The company has a global presence, with significant revenue generated from the Americas, as well as operations in EMEA and APAC. To ensure the continuity and collaborative spirit of the MariaDB ecosystem, the MariaDB Foundation plays a crucial role in supporting the community and maintaining the reliability of MariaDB Server.

OrthAlign

Series D in 2017
OrthAlign, Inc. is a medical device company based in Aliso Viejo, California, specializing in surgical navigation products designed for orthopedic procedures, particularly in joint replacement surgeries. The company offers handheld devices such as KneeAlign for total knee arthroplasty, HipAlign for hip surgeries, and UniAlign for unicompartmental knee arthroplasty. These products utilize precise alignment technology in compact, single-use devices that are compatible with various implant systems. OrthAlign's tools provide critical data related to knee stability, angles, and cup placements, aiming to improve surgical outcomes and enhance patient recovery. The company serves orthopedic surgeons, hospitals, and patients through a global network of distributors, with a mission to establish a new standard of care in total joint replacement. Founded in 2004, OrthAlign was previously known as Vitruvian Orthopaedics, Inc. and rebranded in 2009.

Gamevice

Series A in 2017
Gamevice is a US-based design and engineering company specializing in mobile gaming accessories. The company develops attachable gamepad controllers that enhance the gaming experience by connecting directly to the charging ports of smartphones and tablets. This innovation allows users to transform their devices into advanced mobile gaming consoles. Gamevice has received multiple awards for its products and operates offices in Los Angeles, Hong Kong, London, and has recently opened new locations in Shenzhen, China, serving as its corporate headquarters, research and development hub, and customer support center.

AiVita Biomedical

Series A in 2016
AiVita Biomedical is a biotechnology company focused on advancing commercial and clinical-stage programs that utilize curative and regenerative medicines. Founded in 2016 and based in Irvine, California, the company develops treatments for cancer, including a patient-specific immunotherapy targeting advanced cancers such as glioblastoma and ovarian cancer. Additionally, AiVita Biomedical is engaged in a preclinical program that involves human stem cells differentiated into retinal tissue sheets aimed at treating degenerative retinal diseases. The company's offerings also include a line of rejuvenating skincare products under the ROOT OF SKIN brand, which focuses on anti-aging solutions. Through its expertise in stem cell growth and differentiation, AiVita Biomedical aims to create safe and effective manufacturing systems that support its diverse therapeutic pipeline.

Spine Wave

Series F in 2016
Spine Wave, Inc. is a manufacturer of medical devices focused on the treatment of spinal disorders. Founded in 2001 and based in Shelton, Connecticut, the company develops and markets a range of innovative products aimed at providing surgical solutions for spine surgeons and their patients. Its offerings include expandable PEEK spacers, interbody devices for posterior surgery, pivoting and lateral spacer systems, and the GraftMag Graft Delivery System for bone graft delivery. Additionally, Spine Wave produces fixation products designed for addressing degeneration, deformity, tumors, and trauma in the thoracolumbar spine, as well as anterior cervical plate systems for spinal fusion from C2-C7 and cervical spacer systems for degenerative disc disease from C2-T1. The company distributes its products through a network of distributors, emphasizing a surgeon-driven approach to product development to address real surgical challenges.

MariaDB

Series B in 2016
MariaDB is a cloud database company that specializes in providing next-generation database solutions. Its products have been widely adopted, reaching over a billion users through various Linux distributions and accumulating more than one billion downloads. MariaDB serves a diverse range of industries and use cases, operating primarily within the Software-as-a-Service (SaaS) sector. The company has a global presence, with significant revenue generated from the Americas, as well as operations in EMEA and APAC. To ensure the continuity and collaborative spirit of the MariaDB ecosystem, the MariaDB Foundation plays a crucial role in supporting the community and maintaining the reliability of MariaDB Server.

CyMedica

Series A in 2015
CyMedica Orthopedics, Inc. is a medical device company focused on developing and commercializing innovative products for joint injuries and the associated muscle atrophy. Founded in 2013 and based in Scottsdale, Arizona, CyMedica offers a range of orthopedic solutions that utilize proprietary neuromuscular electrical stimulation technology. Its flagship product, e-vive, provides individualized muscle stimulation therapy through a wireless and app-controlled system, allowing patients to engage in their rehabilitation while tracking progress and sharing data with clinicians. Additionally, the company offers a variety of products, including the Conductive garment, which ensures effective muscle activation, the ACL Brace for post-operative support, and The QB1 System, designed to empower patients in overcoming quadricep weakness. These devices aim to stabilize joints, prevent muscle weakening during recovery, and improve patient outcomes while reducing the likelihood of readmission.

MariaDB

Series B in 2013
MariaDB is a cloud database company that specializes in providing next-generation database solutions. Its products have been widely adopted, reaching over a billion users through various Linux distributions and accumulating more than one billion downloads. MariaDB serves a diverse range of industries and use cases, operating primarily within the Software-as-a-Service (SaaS) sector. The company has a global presence, with significant revenue generated from the Americas, as well as operations in EMEA and APAC. To ensure the continuity and collaborative spirit of the MariaDB ecosystem, the MariaDB Foundation plays a crucial role in supporting the community and maintaining the reliability of MariaDB Server.

VideoCare

Seed Round in 2013
VideoCare, Inc. specializes in technology solutions that help families stay connected with their aging loved ones. The company offers a user-friendly touch-screen video system designed specifically for elderly care recipients, eliminating the need for keyboards or technical skills. This system allows users to share photos, videos, music, and social media content while also managing medication, appointments, and daily activities. VideoCare facilitates remote face-to-face interactions, enabling family members and professional caregivers to provide support and companionship. Additionally, home care agencies and elder facilities can use the platform to enhance connectivity between care recipients and their families or staff. Founded in 2011 and based in Menlo Park, California, VideoCare aims to improve the quality of life for seniors by fostering meaningful connections.

SurgiQuest

Series D in 2012
SurgiQuest is a technology company based in Orange, Connecticut, specializing in solutions for minimally invasive surgery. Established in 2006, the company is known for its AirSeal technology, which creates an air curtain to maintain an insufflated and airtight environment during laparoscopic and laparoscopic-assisted procedures. SurgiQuest's focus spans various surgical fields, including bariatric, colorectal, general, gynecological, and urologic surgery.

Huaxia Dairy Farm

Series C in 2012
Huaxia Dairy Farm Ltd. processes, distributes, and sells milk in China. It offers yogurts, cream puddings, and ice creams. The company also provides feed testing and feed analysis services to other farms and farming companies, as well as processes corn silage. It serves hotels, restaurants, supermarkets, and coffee shops, as well as home delivery customers through its store in Beijing. The company was founded in 2004 and is based in Sanhe, China. Huaxia Dairy Farm Ltd. operates as a subsidiary of China Genetics Holdings Ltd.

Education.com

Venture Round in 2012
Education.com is an online platform that offers educational resources aimed at enhancing the learning experience for children. It provides teachers and parents with a guided curriculum that covers essential skills in subjects such as Math, Reading, Writing, English Language Arts, and Science. The platform serves over 16 million users globally, focusing on preschool and elementary education. Its mission is to inspire children's passion for learning, foster their curiosity, and promote optimism in their educational journey. The resources are designed to empower parents to support their children's academic development effectively.

MariaDB

Series A in 2012
MariaDB is a cloud database company that specializes in providing next-generation database solutions. Its products have been widely adopted, reaching over a billion users through various Linux distributions and accumulating more than one billion downloads. MariaDB serves a diverse range of industries and use cases, operating primarily within the Software-as-a-Service (SaaS) sector. The company has a global presence, with significant revenue generated from the Americas, as well as operations in EMEA and APAC. To ensure the continuity and collaborative spirit of the MariaDB ecosystem, the MariaDB Foundation plays a crucial role in supporting the community and maintaining the reliability of MariaDB Server.

ClearFlow

Series C in 2012
ClearFlow, Inc. is a medical device company specializing in the development and manufacturing of active blood and fluid evacuation systems to address catheter obstructions. The company's primary product, the PleuraFlow Active Clearance Technology system, is designed to clear chest tubes, preventing the retention of blood and fluids in the chest cavity, particularly for pediatric cardiothoracic surgery patients. This innovative technology allows for improved postoperative blood evacuation, enabling the use of minimally invasive drainage tubes, which can enhance patient comfort and reduce surgical complications. ClearFlow is expanding its product pipeline based on its proprietary technologies to tackle catheter clogging across various medical segments, including urinary and gastrointestinal catheters, as well as wound drainage. Founded in 2006 and based in Anaheim, California, the company also operates a service center in Maastricht, the Netherlands.

Education.com

Venture Round in 2012
Education.com is an online platform that offers educational resources aimed at enhancing the learning experience for children. It provides teachers and parents with a guided curriculum that covers essential skills in subjects such as Math, Reading, Writing, English Language Arts, and Science. The platform serves over 16 million users globally, focusing on preschool and elementary education. Its mission is to inspire children's passion for learning, foster their curiosity, and promote optimism in their educational journey. The resources are designed to empower parents to support their children's academic development effectively.

SurgiQuest

Series C in 2011
SurgiQuest is a technology company based in Orange, Connecticut, specializing in solutions for minimally invasive surgery. Established in 2006, the company is known for its AirSeal technology, which creates an air curtain to maintain an insufflated and airtight environment during laparoscopic and laparoscopic-assisted procedures. SurgiQuest's focus spans various surgical fields, including bariatric, colorectal, general, gynecological, and urologic surgery.

OrthAlign

Series A in 2010
OrthAlign, Inc. is a medical device company based in Aliso Viejo, California, specializing in surgical navigation products designed for orthopedic procedures, particularly in joint replacement surgeries. The company offers handheld devices such as KneeAlign for total knee arthroplasty, HipAlign for hip surgeries, and UniAlign for unicompartmental knee arthroplasty. These products utilize precise alignment technology in compact, single-use devices that are compatible with various implant systems. OrthAlign's tools provide critical data related to knee stability, angles, and cup placements, aiming to improve surgical outcomes and enhance patient recovery. The company serves orthopedic surgeons, hospitals, and patients through a global network of distributors, with a mission to establish a new standard of care in total joint replacement. Founded in 2004, OrthAlign was previously known as Vitruvian Orthopaedics, Inc. and rebranded in 2009.

Blade Games World

Debt Financing in 2009
Blade Games World develops and publishes Jumala, a free gaming destination that brings game creation to everyone - no experience or programming skills required. Whether enjoying games made by others or playing the “game” of creating your own, Jumala blends game play, game creation and an interactive community into a single, immersive and fun experience. Jumala unleashes creative possibilities as vast and unique as your imagination. Blade Games is led by an experienced team of game development professionals and is based in Bellevue, WA. For more information, please visit www.jumala.com.

Blade Games World

Venture Round in 2009
Blade Games World develops and publishes Jumala, a free gaming destination that brings game creation to everyone - no experience or programming skills required. Whether enjoying games made by others or playing the “game” of creating your own, Jumala blends game play, game creation and an interactive community into a single, immersive and fun experience. Jumala unleashes creative possibilities as vast and unique as your imagination. Blade Games is led by an experienced team of game development professionals and is based in Bellevue, WA. For more information, please visit www.jumala.com.

TravelMuse

Series A in 2008
TravelMuse.com is an online travel planning platform designed to enhance the travel planning experience by offering a combination of inspiring content and practical tools. It features captivating photography, professionally written articles, and a collection of licensed city guides, all aimed at helping users make informed travel decisions. Founded by a team of enthusiastic travelers with diverse backgrounds in technology, travel, and media, TravelMuse is committed to improving how people plan their trips. The platform includes an innovative Inspiration Finder to help users discover new destinations, a TravelMuse Planner for organizing vacation plans, and a comprehensive booking engine that allows users to make reservations for flights, hotels, car rentals, cruises, and travel packages.

OrthoScan

Series B in 2008
OrthoScan, Inc. is a medical device company based in Scottsdale, Arizona, specializing in the development and manufacture of orthopedic imaging devices. Founded in 2002, the company focuses on providing innovative solutions for anatomical visualization in surgical settings. Its product line includes the ORTHOSCAN FD PULSE, a flat detector C-arm that enhances field of view for surgeons, and the ORTHOSCAN MOBILE DI unit, designed for mobility between various clinical environments. Other offerings include the ORTHOSCAN FD-OR for optimal positioning in surgery, the ORTHOSCAN HD mini C-arm, and accessories such as mini drapes and protective aprons. OrthoScan aims to improve the efficiency and effectiveness of imaging in orthopedic procedures, catering to the needs of healthcare professionals in both surgical and clinical contexts.

Education.com

Series B in 2008
Education.com is an online platform that offers educational resources aimed at enhancing the learning experience for children. It provides teachers and parents with a guided curriculum that covers essential skills in subjects such as Math, Reading, Writing, English Language Arts, and Science. The platform serves over 16 million users globally, focusing on preschool and elementary education. Its mission is to inspire children's passion for learning, foster their curiosity, and promote optimism in their educational journey. The resources are designed to empower parents to support their children's academic development effectively.

AngioScore

Series E in 2007
AngioScore Inc. is engaged in the development, manufacturing, and marketing of medical devices, specifically focusing on the AngioSculpt Scoring Balloon Catheter. This catheter is designed for use in both coronary and peripheral interventional markets, addressing the limitations commonly associated with traditional angioplasty balloon catheters. The AngioSculpt features a semi-compliant balloon combined with a unique nitinol scoring element, enhancing its effectiveness in endovascular therapy. The company's products are aimed at improving the treatment of cardiovascular and vascular diseases.

Thinglefin

Series A in 2007
Thinglefin is a venture-backed start-up based in the Seattle area, founded by industry veterans Toby Ragaini, Jeremy Friesen, and Ryan O’Rourke, who have extensive experience with renowned companies such as Sony, Microsoft, Sega, Monolith, and Wild Tangent. The company specializes in developing multiplayer online casual games and is currently working on an unannounced web-based massively multiplayer game aimed at enhancing engaging gameplay and accessibility for players.

Ceregene

Series C in 2007
Ceregene is a privately held biotechnology company based in San Diego, specializing in the treatment of major neurodegenerative disorders through the delivery of nervous system growth factors. The company's clinical programs feature CERE-110, an AAV2-based vector expressing nerve growth factor, which is set to enter Phase 2 studies for Alzheimer's disease. Additionally, CERE-120 has recently completed a Phase 2 trial for Parkinson's disease and is under evaluation for future development. Ceregene is also advancing two other treatments, CERE-135 and CERE-140, which are in preclinical stages targeting amyotrophic lateral sclerosis (ALS) and ocular diseases, respectively.

TravelMuse

Seed Round in 2007
TravelMuse.com is an online travel planning platform designed to enhance the travel planning experience by offering a combination of inspiring content and practical tools. It features captivating photography, professionally written articles, and a collection of licensed city guides, all aimed at helping users make informed travel decisions. Founded by a team of enthusiastic travelers with diverse backgrounds in technology, travel, and media, TravelMuse is committed to improving how people plan their trips. The platform includes an innovative Inspiration Finder to help users discover new destinations, a TravelMuse Planner for organizing vacation plans, and a comprehensive booking engine that allows users to make reservations for flights, hotels, car rentals, cruises, and travel packages.

SurgRx

Series F in 2007
SurgRx is a developer of laparoscopic vessel fusion tools for surgical hemostasis.

Spine Wave

Series D in 2007
Spine Wave, Inc. is a manufacturer of medical devices focused on the treatment of spinal disorders. Founded in 2001 and based in Shelton, Connecticut, the company develops and markets a range of innovative products aimed at providing surgical solutions for spine surgeons and their patients. Its offerings include expandable PEEK spacers, interbody devices for posterior surgery, pivoting and lateral spacer systems, and the GraftMag Graft Delivery System for bone graft delivery. Additionally, Spine Wave produces fixation products designed for addressing degeneration, deformity, tumors, and trauma in the thoracolumbar spine, as well as anterior cervical plate systems for spinal fusion from C2-C7 and cervical spacer systems for degenerative disc disease from C2-T1. The company distributes its products through a network of distributors, emphasizing a surgeon-driven approach to product development to address real surgical challenges.

Health Hero Networks

Series B in 2006
Health Hero Network, Inc. specializes in developing technology solutions for remote health monitoring and management, primarily aimed at enhancing communication between patients and healthcare providers. The company offers a comprehensive Health Buddy system that facilitates patient education and chronic condition monitoring, integrating various technologies and clinical information databases. Its services cater to a diverse clientele, including hospitals, health plans, government health organizations, disease management firms, and pharmaceutical companies involved in clinical trials. Founded in 1988 and based in Palo Alto, California, Health Hero Network operates as a subsidiary of Robert Bosch GMBH, focusing on delivering personalized health management programs that enable providers to effectively monitor patient health and make informed decisions.

AngioScore

Series D in 2006
AngioScore Inc. is engaged in the development, manufacturing, and marketing of medical devices, specifically focusing on the AngioSculpt Scoring Balloon Catheter. This catheter is designed for use in both coronary and peripheral interventional markets, addressing the limitations commonly associated with traditional angioplasty balloon catheters. The AngioSculpt features a semi-compliant balloon combined with a unique nitinol scoring element, enhancing its effectiveness in endovascular therapy. The company's products are aimed at improving the treatment of cardiovascular and vascular diseases.

Spine Wave

Series C in 2006
Spine Wave, Inc. is a manufacturer of medical devices focused on the treatment of spinal disorders. Founded in 2001 and based in Shelton, Connecticut, the company develops and markets a range of innovative products aimed at providing surgical solutions for spine surgeons and their patients. Its offerings include expandable PEEK spacers, interbody devices for posterior surgery, pivoting and lateral spacer systems, and the GraftMag Graft Delivery System for bone graft delivery. Additionally, Spine Wave produces fixation products designed for addressing degeneration, deformity, tumors, and trauma in the thoracolumbar spine, as well as anterior cervical plate systems for spinal fusion from C2-C7 and cervical spacer systems for degenerative disc disease from C2-T1. The company distributes its products through a network of distributors, emphasizing a surgeon-driven approach to product development to address real surgical challenges.

SurgRx

Series D in 2004
SurgRx is a developer of laparoscopic vessel fusion tools for surgical hemostasis.

AngioScore

Series B in 2004
AngioScore Inc. is engaged in the development, manufacturing, and marketing of medical devices, specifically focusing on the AngioSculpt Scoring Balloon Catheter. This catheter is designed for use in both coronary and peripheral interventional markets, addressing the limitations commonly associated with traditional angioplasty balloon catheters. The AngioSculpt features a semi-compliant balloon combined with a unique nitinol scoring element, enhancing its effectiveness in endovascular therapy. The company's products are aimed at improving the treatment of cardiovascular and vascular diseases.

Ceregene

Series B in 2004
Ceregene is a privately held biotechnology company based in San Diego, specializing in the treatment of major neurodegenerative disorders through the delivery of nervous system growth factors. The company's clinical programs feature CERE-110, an AAV2-based vector expressing nerve growth factor, which is set to enter Phase 2 studies for Alzheimer's disease. Additionally, CERE-120 has recently completed a Phase 2 trial for Parkinson's disease and is under evaluation for future development. Ceregene is also advancing two other treatments, CERE-135 and CERE-140, which are in preclinical stages targeting amyotrophic lateral sclerosis (ALS) and ocular diseases, respectively.

SurgRx

Series C in 2004
SurgRx is a developer of laparoscopic vessel fusion tools for surgical hemostasis.

Vivant Medical

Venture Round in 2004
Vivant Medical is an Information Technology company.

SurgRx

Series B in 2003
SurgRx is a developer of laparoscopic vessel fusion tools for surgical hemostasis.

PhotoThera

Series A in 2001
PhotoThera is currently hiring for the following positions: Sr. Software Engineer Mechanical Engineer Configuration Management Engineer Sr. Electrical Engineer Send your resume and cover letter to ktitano@photothera.com, or go to www.photothera.com for further information. Specialties laser, medical device, eschemic, stroke, infrared
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.